This localized delivery approach is intended to maximize anti-tumor activity within the bladder lining and enhance bladder preservation, making TAR‑210 a promising bladder-sparing option for patients ...
India's top drug advisory panel has approved Natco Pharma's request to make and sell erdafitinib tablets by skipping a Phase-III trial but needing a post-launch study in Phase IV... .
By Pat Graham . Associated Press. BOULDER, Colo ... Sanders has hit the ground running since recently returning to the team after treatment for bladder cancer ...Last month, he disclosed he had been diagnosed with an aggressive form of bladder cancer ... .